>Remdesivir has a minor beneficial impact when delivered VERY EARLY.
There's still a couple of problems though:
* It has to be delivered by IV drip
* It's in short supply
* It's expensive
Which means that realistically, the only way to get a positive impact from it would be to send high-risk patients who were very likely to have just been exposed to the hospital for the injection. Even then, the risk-value proposition does not seem that great.
None of these three points is the bottleneck. It's still easy to give someone an IV early on if they're in a high-risk group, it's not in that short supply, and at ~$2500 per treatment regimen it's not that expensive compared to an extended hospital stay.
The bottleneck is that it's only slightly effective.
It’ll be a means for the rich to lessen their pain. Nothing more. Let’s be honest.
No hospital would take you in on slight symptoms. The drug alone costs $3,000+, it’s basically US-only and thus needs to be administered there, which will end up costing about as much again.
See the top 0.01% hold some remdesivir in their mansions for their private physician to administer.
Yes a minor impact, that doesn't really show that it saves lives at all. Just that generally those who take the drug early on are out of bed a couple of days earlier than others. Not really worth 2000USD a pop. Sounds like a big pharma scam to me. Same with the Chloroquin
There's still a couple of problems though:
* It has to be delivered by IV drip
* It's in short supply
* It's expensive
Which means that realistically, the only way to get a positive impact from it would be to send high-risk patients who were very likely to have just been exposed to the hospital for the injection. Even then, the risk-value proposition does not seem that great.